ClinicalTrials.Veeva

Menu
R

River Region Dermatology and Laser | C2 Research Center

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Dupilumab
Lebrikizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 1 total trial

A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab (ADapt)

The study will assess the safety and efficacy of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD) pre...

Active, not recruiting
Atopic Dermatitis
Drug: Lebrikizumab

Trial sponsors

Lilly logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems